NEFL and COVID-19: The inconsistent evidence surrounding the role of NfL may stem from the possibility that subtle neuroaxonal injury can occur in asymptomatic and pauci-symptomatic COVID-19 patients, and that various factors might influence NfL levels, making this biomarker non-specific.